214760-36-8 Usage
Uses
Used in Plastics and Textile Industry:
1,2-Benzisoxazol-5-ol, 3-methyl(9CI) is used as a fluorescent brightener for enhancing the appearance of plastics and textiles. Its incorporation into these materials results in improved brightness and color vibrancy, providing a visually appealing finish.
Used in Paper Industry:
In the paper industry, 1,2-Benzisoxazol-5-ol, 3-methyl(9CI) is utilized in the formulation of optical brightening agents. These agents are added to paper products to increase their whiteness and brightness, improving the overall aesthetic quality and readability.
Used in Pharmaceutical Synthesis:
1,2-Benzisoxazol-5-ol, 3-methyl(9CI) is employed as a key intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Agricultural Chemicals:
1,2-Benzisoxazol-5-ol, 3-methyl(9CI) is also utilized in the synthesis of agricultural chemicals, such as pesticides and herbicides. Its versatile reactivity enables the creation of novel compounds with improved efficacy and selectivity in controlling pests and weeds.
Used in Biological Research:
1,2-Benzisoxazol-5-ol, 3-methyl(9CI) has been studied for its potential biological activity, including anti-cancer and anti-inflammatory properties. Although further research is needed to fully understand its effects, it holds promise as a potential therapeutic agent in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 214760-36-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,7,6 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 214760-36:
(8*2)+(7*1)+(6*4)+(5*7)+(4*6)+(3*0)+(2*3)+(1*6)=118
118 % 10 = 8
So 214760-36-8 is a valid CAS Registry Number.
214760-36-8Relevant academic research and scientific papers
Amino sulfonyl compound, preparation method and uses thereof
-
Paragraph 0186; 0188, (2016/12/01)
The present invention relates to a new amino sulfonyl compound represented by a general formula I, or a tautomer, an enantiomer, a racemate or a pharmaceutically acceptable salt thereof, a preparation method, a pharmaceutical composition, and uses thereof, wherein the compound can be used for treatment of epilepsy, convulsion, obesity, and the like. The general formula I is defined in the specification.
